Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells

Journal of Leukocyte Biology

Volumn 77, Issue 3, 2005, Pages 378-387

  Jahrsdörfer, Bernd ^a   Wooldridge, James E ^a,b   Blackwell, Sue E ^a   Taylor, Christiana M ^a   Griffith, Thomas S ^a,b   Link, Brian K ^a,b   Weiner, George J ^a,b  

^a UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^b UNIVERSITY OF IOWA   (United States)

Author keywords

B CLL; Caspase; CpG ODN; Cytogenetic status

Indexed keywords

APOPTOSIS INHIBITOR; CASPASE; FAS ANTIGEN; OLIGODEOXYNUCLEOTIDE; TOLL LIKE RECEPTOR 9;

ADULT; AGED; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CHROMOSOME 11Q; CHROMOSOME 13Q; CHROMOSOME 17P; CHROMOSOME ABERRATION; CHROMOSOME DELETION; CHROMOSOME DELETION 13; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; CYTOGENETICS; DRUG MECHANISM; ENZYME ACTIVATION; FEMALE; HUMAN; IMMUNOGENICITY; IMMUNOSTIMULATION; LEUKEMIA CELL; LYMPHATIC LEUKEMIA; MALE; PHENOTYPE; PRIORITY JOURNAL; TRISOMY 21; UPREGULATION;

AGED; AGED, 80 AND OVER; ANTIGENS, CD95; APOPTOSIS; CASPASES; DNA-BINDING PROTEINS; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, B-CELL, CHRONIC; LIGANDS; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES; RECEPTORS, CELL SURFACE; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; TOLL-LIKE RECEPTOR 9;

EID: 14244268126     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0604373     Document Type: Article

References (20)

1. O'Brien, S., Del Giglio, A., Keating, M. (1995) Advances in the biology and treatment of B-cell chronic lymphocytic leukemia. Blood 85, 307-318.
2. Dohner, H., Stilgenbauer, S., Benner, A., Leupolt, E., Krober, A., Bullinger, L., Dohner, K., Bentz, M., Lichter, P. (2000) Genomic aberrations and survival in chronic lymphocytic leukemia. N. Engl. J. Med. 343, 1910-1916.
3. Van den Hove, L. E., Van Gool, S. W., Vandenberghe, P., Bakkus, M., Thielemans, K., Boogaerts, M. A., Ceuppens, J. L. (1997) CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules. Leukemia 11, 572-580.
4. Donepudi, M., Jovasevic, V. M., Raychaudhuri, P., Mokyr, M. B. (2003) Melphalan-induced up-regulation of B7-1 surface expression on normal splenic B cells. Cancer Immunol. Immunother. 52, 162-170.
5. Wendtner, C. M., Kofler, D. M., Theiss, H. D., Kurzeder, C., Buhmann, R., Schweighofer, C., Perabo, L., Danhauser-Riedl, S., Baumert, J., Hiddemann, W., Hallek, M., Buning, H. (2002) Efficient gene transfer of CD40 ligand into primary B-CLL cells using recombinant adeno-associated virus (rAAV) vectors. Blood 100, 1655-1661.
6. Chu, P., Deforce, D., Pedersen, I. M., Kim, Y., Kitada, S., Reed, J. C., Kipps, T. J. (2002) Latent sensitivity to Fas-mediated apoptosis after CD40 ligation may explain activity of CD154 gene therapy in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 99, 3854-3859.
7. Tretter, T., Schuler, M., Schneller, F., Brass, U., Esswein, M., Aman, M. J., Huber, C., Peschel, C. (1998) Direct cellular interaction with activated CD4(+) T cells overcomes hyporesponsiveness of B-cell chronic lymphocytic leukemia in vitro. Cell. Immunol. 189, 41-50.
8. Anether, G., Marschitz, I., Tinhofer, I., Greil, R. (2002) Interleukin-15 as a potential costimulatory cytokine in CD154 gene therapy of chronic lymphocytic leukemia. Blood 99, 722-723.
9. Jahrsdörfer, B., Hartmann, G., Racila, E., Jackson, W., Mühlenhoff, L., Meinhardt, G., Endres, S., Link, B., Krieg, A., Weiner, G. (2001) CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens. J. Leukoc. Biol. 69, 81-88.
10. Jahrsdörfer, B., Jox, R., Muhlenhoff, L., Tschoep, K., Krug, A., Rothenfusser, S., Meinhardt, G., Emmerich, B., Endres, S., Hartmann, G. (2002) Modulation of malignant B cell activation and apoptosis by bcl-2 antisense ODN and immunostimulatory CpG ODN. J. Leukoc. Biol. 72, 83-92.
11. Decker, T., Schneller, F., Kronschnabl, M., Dechow, T., Lipford, G. B., Wagner, H., Peschel, C. (2000) Immunostimulatory CpG-oligodeoxynucleotides induce functional high-affinity IL-2 receptors on B-CLL cells: costimulation with IL-2 results in a highly immunogenic phenotype. Exp. Hematol. 28, 558-568.
12. Decker, T., Schneller, F., Sparwasser, T., Tretter, T., Lipford, G. B., Wagner, H., Peschel, C. (2000) Immunostimulatory CpG-oligodeoxynucleotides cause proliferation, cytokine production, and an immunogenic phenotype in chronic lymphocytic leukemia B cells. Blood 95, 999-1006.
13. Krieg, A. M., Yi, A. K., Matson, S., Waldschmidt, T. J., Bishop, G. A., Teasdale, R., Koretzky, G. A., Klinman, D. M. (1995) CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374, 546-549.
14. Bernasconi, N. L., Traggiai, E., Lanzavecchia, A. (2002) Maintenance of serological memory by polyclonal activation of human memory B cells. Science 298, 2199-2202.
15. Hartmann, G., Krug, A., Eigler, A., Moeller, J., Murphy, J., Albrecht, R., Endres, S. (1996) Specific suppression of human tumor necrosis factor-α synthesis by antisense oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev. 6, 291-299.
16. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., Endres, S., Hartmann, G. (2002) Quantitative expression of Toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. J. Immunol. 168, 4531-4537.
17. Barton, G. M., Medzhitov, R. (2002) Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 270, 81-92.
18. Decker, T., Peschel, C. (2001) Effect of immunostimulatory CpG-oligodeoxynucleotides in chronic lymphocytic leukemia B cells. Leuk. Lymphoma 42, 301-307.
19. Orchard, J. A., Ibbotson, R. E., Davis, Z., Wiestner, A., Rosenwald, A., Thomas, P. W., Hamblin, T. J., Staudt, L. M., Oscier, D. G. (2004) ZAP-70 expression and prognosis in chronic lymphocytic leukaemia. Lancet 363, 105-111.
20. Kienle, D., Korz, C., Hosch, B., Kroeber, A., Habermann, A., Benner, A., Lichter, P., Doehner, H., Stilgenbauer, S. (2003) Evidence for distinct pathomechanisms in genetic subgroups of CLL by quantitative expression analysis of cell cycle, activation-, and apoptosis-associated genes. 45. Annual Meeting of the American Society of Hematology 102, 187a-188a.